Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.015 CAD | -.--% | -.--% | -25.00% |
04-26 | Blueberries Medical Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Blueberries Medical Corp. announced that it has received CAD 1.987876 million in funding | CI |
Sales 2022 | 0.24 0.32 18.85 | Sales 2023 | 0.29 0.4 23.08 | Capitalization | 7.98M 10.98M 639M |
---|---|---|---|---|---|
Net income 2022 | -1M -1.38M -80.05M | Net income 2023 | -1M -1.38M -80.05M | EV / Sales 2022 | 18,219,899 x |
Net cash position 2022 | 76.33K 105K 6.11M | Net cash position 2023 | 805K 1.11M 64.47M | EV / Sales 2023 | 24,890,204 x |
P/E ratio 2022 |
-2.3
x | P/E ratio 2023 |
-2.68
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 40.21% |
Current month | -25.00% | ||
1 month | -25.00% | ||
3 months | -40.00% | ||
Current year | -25.00% |
Managers | Title | Age | Since |
---|---|---|---|
Facundo Garretón
CEO | Chief Executive Officer | - | 19/01/21 |
Director of Finance/CFO | - | 31/05/21 | |
Corporate Officer/Principal | - | 15/02/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Facundo Garretón
CEO | Chief Executive Officer | - | 19/01/21 |
Director/Board Member | - | - | |
Director/Board Member | 49 | - |
Date | Price | Change | Volume |
---|---|---|---|
30/04/24 | 0.015 | -.--% | 78,666 |
26/04/24 | 0.015 | -.--% | 340,333 |
25/04/24 | 0.015 | -.--% | 535,133 |
Delayed Quote Canadian Securities Exchange, April 30, 2024 at 08:51 pm
More quotes1st Jan change | Capi. | |
---|---|---|
-25.00% | 4.35M | |
+41.56% | 3.65B | |
+15.65% | 2.15B | |
+118.82% | 741M | |
+34.09% | 625M | |
+48.36% | 182M | |
+8.64% | 104M | |
+57.30% | 58.4M |
- Stock Market
- Equities
- BBM Stock